参考文献/References:
[1] 曹王丽,宋佳希,李芳秋.单克隆抗体靶向治疗卵巢癌研究进展[J].医学研究生学报,2013,26(5):536-540.
Cao WL,Song JX,Li FQ.Monoclonal antibody-based targeted therapyfor ovarian cancer[J].J Med Postgra,2013,26(5):536-540.
[2] 王 莹,续 薇.血清人附睾分泌蛋白4联合CA125检测对卵巢癌的诊断价值[J].中国实验诊断学,2013,17(11):2079-2081.
Wang Y,Xu W.Clinical diagnosis value of serum human epididymis protein 4 with carbohydrate antigen 125 in ovarian cancer[J].Chin J Lab Diagn,2013,17(11):2079-2081.
[3] 武建国.卵巢癌的生物标志物[J].临床检验杂志,2012,30(2):84-88.
Wu JG.Biological marker of ovarian cancer[J].Chinese Journal ofClinical Laboratory Science,2012,30(2):84-88.
[4] Zheng H,Gao YN.Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease[J].Int J Gynecol Cancer,2012,22(6):1000-1005.
[5] 郑 虹,高雨农,高维娇,等.卵巢上皮癌患者血清中人附睾蛋白4的水平及其与预后的相关性[J].中华肿瘤杂志,2013,35(6):445-449.
Zheng H,Gao YN,Gao WJ,et al.Expression of serum human epididymisprotein 4 in epithelial ovarian cancer and its correlation with prognosis[J].Chin J Oncol,2013,35(6): 445-449.
[6] Kirchhoff C,Habben I,Ivell R,et al.A major human epididymis-specificcDNA encodes a protein with sequence homology to extracellular proteinase inhibitors[J].Biol Reprod,1991,45(2):350-357.
[7] Lu R, Sun X, Xiao R, et al. Human epididymis protein 4(HE4)plays a key role in ovarian cancer cell adhesion and motility[J].Bionchem Biophys ResCommun,2012,419(2):274-280.
[8] Bast RC,Feeney M,Lazarus H,et al.Reactivity of a monoclonal antibodywith human ovarian carcinoma[J].J Clin Invest,1981,68(5):1331-1337.
[9] Hogdall EV, Christensen L, Kjaer SK,et al.CA125 expression pattern,prognosis and correlation with serum CA125 in ovarian tumor patients.From The Danish “MALOVA” Ovaina Cancer Study[J].Gynecol Oncol,2007,104(3):508-515.
[10] 陈 璐,孙 敬,陈 琛.人附睾蛋白在卵巢癌诊断中的应用[J].医学研究生学报,2013,26(8):836-838.
Chen L,Sun J,Chen C.Application of human epididymis protein 4 in the diagnosis for ovarian cancer[J].J Med Postgra,2013,26(8):836-838.
[11] Holcomb K,Vucetic Z,Miller MC,et al.Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women[J].Am J Obstet Gynecol,2011,205(4):358.e1-6.
[12] Li F,Tie R,Chang K,et al.Dose risk for ovarian malignancy algorithmexcel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer:A meta-analysis[J].BMC cancer,2012(12):258.
相似文献/References:
[1]赵智凝,武 易,刘 芳,等.慢性肾病患者血清Klotho，HE4，UMOD表达水平与疾病预后的相关性研究[J].现代检验医学杂志,2021,36(02):28.[doi:doi:10.3969/j.issn.1671-7414.2021.02.007]
ZHAO Zhi-ning,WU Yi,LIU Fang,et al.Study on the Relationship between the Expression Level of Klotho, HE4 and Uromodulin and the Development of Chronic Kidney Disease[J].Journal of Modern Laboratory Medicine,2021,36(01):28.[doi:doi:10.3969/j.issn.1671-7414.2021.02.007]
[2]刘 检,李 敏,陆明洋,等.卵巢癌患者血液NLR，CA125，HE4水平联合检测的实验诊断和预后价值研究[J].现代检验医学杂志,2021,36(05):28.[doi:10.3969/j.issn.1671-7414.2021.05.006]
LIU Jian,LI Min,LU Ming-yang,et al.Experimental Diagnosis and Prognostic Value of Combined Detection of BloodNLR, CA125 and HE4 Levels in Ovarian Cancer Patients[J].Journal of Modern Laboratory Medicine,2021,36(01):28.[doi:10.3969/j.issn.1671-7414.2021.05.006]